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ScienceDirectThough established 40 years ago, the field of de novo protein
design has recently come of age, with new designs exhibiting
an unprecedented level of sophistication in structure and
function. With respect to catalysis, de novo enzymes promise
to revolutionise the industrial production of useful chemicals
and materials, while providing new biomolecules as plug-and-
play components in the metabolic pathways of living cells. To
this end, there are now de novo metalloenzymes that are
assembled in vivo, including the recently reported C45
maquette, which can catalyse a variety of substrate oxidations
with efficiencies rivalling those of closely related natural
enzymes. Here we explore the successful design of this de
novo enzyme, which was designed to minimise the undesirable
complexity of natural proteins using a minimalistic bottom-up
approach.
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The design of novel proteins
De novo protein design has its roots in the 1970s with the
design of functional peptides that aimed to understand
the rules governing the relationship of amino acid
sequence with higher order structure and function [1–
3]. Since then, the field has flourished with advances in
technology, protein structure prediction and recombinant
protein expression [4], with designs that mimic [5,6],
supersede [7] or perform chemistry not seen in nature [8].
Through this we may further our understanding of how
natural proteins operate [9], or augment the functional
possibilities currently available to us from nature’s reper-
toire of proteins. The simplicity of most de novo proteins is
an advantage over the often complex and intricate char-
acteristics and interactions of natural proteins; millennia
of natural selection have imprinted and consolidated thiswww.sciencedirect.com complexity on natural proteins, with many individual
amino acids becoming irreversibly dependent on each
other [10,11]. Therefore, it is not always straightforward
to replicate function in a de novo designed protein by
importing natural sequences. In this review we discuss a
bottom-up approach to de novo protein design, based on
bundles of four alpha-helices, in which the complexity of
natural proteins is avoided.
The first de novo four-helix bundle proteins were
designed in the late 1980s by DeGrado in which repeated
amino acid heptads form a structure with each individual
amino acid having a well-defined role [12]. Heptads of
amino acid residues with high helical forming propensi-
ties form two turns of an alpha helix, helix length can be
tailored by building up a series of heptad repeats, and
linked with loops containing residues with low helix-
forming propensities. Protein folding is driven by the
exclusion of water from the protein core through the
patterning of polar and nonpolar residues [12]. These
simple principles have formed the basis of many de novo
protein designs, although there are designs that are made
up of beta-strand elements [13–15].
Novel protein scaffolds may be designed rationally to
achieve a particular function, and/or use directed evolu-
tion to evolve towards or refine the desired activity.
Developments in high throughput techniques have facil-
itated the construction and screening of large protein
libraries [16,17], while the use of computational design
has increasingly allowed us to design scaffolds whose
experimentally determined structure remains faithful to
that of the intended design [15]. While many de novo
proteins were designed with a specific function in mind
[6], other functionalities were more serendipitous [18].
Many designs take inspiration from natural structures
[19], or incorporate natural sequences [20].
In this review we discuss a strategy for the successful
design of de novo enzymes, and in particular we discuss
our use of the maquette approach [21], in which we
design an evolutionary naı¨ve, robust structure built from
the minimum number of amino acids possible, and use a
cofactor to imprint function [22]. In this review we
challenge some design principles surmised from natural
proteins: complexity, specificity, and a defined structure,
and examine whether they are strictly necessary for an
effective de novo-designed biological catalyst.
The maquette approach to protein design
Maquettes are de novo-designed self-assembling peptide
scaffolds pioneered by Dutton and colleagues. They areCurrent Opinion in Structural Biology 2018, 51:149–155
150 Engineering & designdesigned bottom-up without mimicking natural
sequences with the intention of minimising the complex-
ity present in naturally evolved proteins, and are subject
to iterative rounds of design with significant engineering
freedom [21,23,24]. Maquette functions to date are
diverse, recent examples include light harvesting [25]
and subsequent energy transfer [26], oxygen binding
[27], oxidation and oxidative dehalogenation catalysis
[22], amphiphilic maquettes for transmembrane elec-
tron transfer [28], and magnetic field sensing [29].
Function is conferred onto a maquette scaffold through
the incorporation of cofactor molecules, and many
maquette designs contain heme. A large amount of natu-
ral proteins contain heme, exhibiting an exceptionally
diverse range of functions including electron transfer,
catalysis, sensing, and transport [30], and in fact heme
may have been utilised by early enzymes as a way to
incorporate activity [18,31]. Many heme-containing pro-
teins are alpha helical structures, including simple 4-helix
bundles [18,30], the scaffold used in most maquette
designs. Heme has therefore proven a useful cofactor
to incorporate into artificial proteins, particularly due to
the ease by which it can be incorporated: heme B can be
ligated through two histidine residues on the interiorFigure 1
The evolution of C45 from humble beginnings. (a) Evolutionary diagram disp
simple featureless 4-helix bundle (1) [35], to the oxygen binding HP7 maque
Sequence alignment of three maquettes from the evolutionary diagram of C
type cytochrome consensus motif (CXXCH) is highlighted in red, and the int
Current Opinion in Structural Biology 2018, 51:149–155 faces of neighbouring helices, and multiple hemes can
be bound within a monomeric scaffold [32,33]. The first
maquette design was based on the bis-histidine heme
binding sites in the respiratory bc1 complex [19], with the
heme-ligating residues located along the hydrophobic
helix interfaces.
Early maquettes were dimeric, comprising synthesized
peptides each with 2 helices connected by linking loops.
A subsequent design, HP7 (Figure 1(2)) has an O2-bind-
ing heme and features helix–loop–helix monomers linked
by a covalent disulphide bond ‘candelabra’ geometry
[34,35]. More recent maquettes have utilised single poly-
peptide chains (Figure 1(3)) thereby avoiding the sym-
metry-induced constraints of earlier designs; these scaf-
folds have been used to reproduce oxidoreductase
functions with activities comparable to their natural coun-
terparts [22,36,37]. Single-chain scaffolds have advan-
tages including the ability to incorporate single site
mutations or covalent modifications, and they can be
expressed in vivo [36].
The maquette approach has proven effective in confer-
ring function onto a simple scaffold, thus challenging the
necessity of the complexity observed in natural proteins.laying the broad design strokes and functions of the maquettes from a
tte (2) [35], to the functional de novo enzyme C45 (3) [22]. (b)
45. Heme-ligating histidines are highlighted in blue, CXXC from the c-
erhelical loops are displayed in purple.
www.sciencedirect.com
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catalysis?
While natural proteins can be complex, de novo protein
design has proven that we can build catalytic function
onto a relatively simple scaffold. Many successful de novo
protein designs that can perform catalysis are made up of
bundles of alpha helices, with activities including the
hydration of CO2 [6], catalase activity [38], enantiospe-
cific hydrolysis [39], oxidation and hydroxylation [40,41],
and there are some that can rescue auxotroph E. coli
strains [39]. De novo catalytic proteins have been assem-
bled from more complex structures, such as the hydrolytic
barrel designed by Burton and colleagues [42]. However,
an advantage of the bottom-up minimalist approach taken
in maquette design is that more complex structures and
catalytic function can be built up iteratively. In this way it
is easy to determine the function of any one amino acid,
facilitating the addition of mutations. We propose that a
simple helix bundle is the best starting point for many
forms of catalysis, particularly as it has been demonstrated
that alpha helical bundle proteins are amenable to expres-
sion in vivo [22], whereas more complex designs may
require peptide synthesis or full assembly in vitro.
While there are many types of catalytic activity that can be
performed by de novo designed proteins, the remainder of
this review will focus on oxidoreductase activity. Oxidor-
eductases are an exceptionally large and important enzyme
family, with many functions involving the transfer of elec-
trons from a donor molecule to an acceptor. Heme-contain-
ing peroxidases that catalyse substrate oxidation coupled to
H2O2 reduction coordinate the catalytic heme by a single
histidine side chain, leaving the 6th coordination site free to
bind a substrate molecule [43]; the simplicity of this design
lends itself to incorporation into a de novo scaffold. It is well
known that the requirements for peroxidase activity are
minimal. For example, the mimochrome family of artificial
proteins which have been designed to maintain the prop-
erties of heme within a minimal protein scaffold [44]. They
consist of two polypeptide chains <14 residues long, and
heme. When the heme is 5-coordinate, mimochromes have
peroxidase ability, oxidising ABTS in the presence of H2O2
[45]. Not only is such a small scaffold capable of facilitating
catalytic ability, mutations to the sequence can fine tune
the reactivity.
There has been much interest in incorporating these
characteristics into maquettes [27,33,37]. De novo proteins
containing heme C are advantageous in that the irrevers-
ible covalent binding of the heme to the protein back-
bone facilitates purification of the functional holoprotein
after expression, and, importantly, provide an opportunity
for supporting a 5-coordinate heme, with one site free for
substrate binding and catalysis.
B-type heme-binding maquettes can be converted to a
covalently-bound c-type by using the conserved c-typewww.sciencedirect.com binding motif, CX1X2CH [36]. Despite their unnatural
protein sequences, c-type maquettes are fully assembled
in E. coli through the addition of a periplasmic export tag
and the co-expression of the type I c-type cytochrome
maturation (Ccm) machinery [22,36]. This results in the
covalent binding of heme through the heme vinyl groups
and protein cysteine residues [36]. The maquette C45
arose from the mutation of previous c-type maquette
designs to produce a single-chain maquette with a
mono-histidine ligated heme [22]. C45 has the basic
requirements of a peroxidase in that the heme cofactor is
solvent exposed and can bind peroxides on its distal
coordination site. Furthermore, the reaction between
C45 and H2O2/ABTS (2,2
0-azino-bis(3-ethylbenzothiazo-
line-6-sulfonic acid)) follows the kinetics of natural per-
oxidases, even matching the catalytic efficiency of horse
radish peroxidase (HRP) operating at its optimum.
The ability to perform efficient catalysis even in an
extremely simplified scaffold compared to the complexity
of natural proteins leads us to pose the question: how
important is a defined structure in catalysis?
How important is a defined structure in
catalysis?
Protein design has utilised the basic requirements for
protein folding in which thermodynamic requirements for
the assembly of secondary structure are satisfied by using
simple heptad patterning of the residues comprising the
alpha helices. The folding of alpha helical units into a
bundle may then follow the principles of natural proteins
in which the hydrophobic interior residues are hidden
from the aqueous solvent [12]. Such structure is necessary
over a disordered unfolded peptide sequence to ensure
stability, to facilitate structure prediction and to prevent
aggregation, for example for in vivo expression.
In nature, structure is often very important for catalysis, in
which the precise arrangement of active site amino acid
side chains is imperative [46,47]. It is thought that the
active site of an enzyme stabilises the transition state over
the substrate, thus lowering the activation energy
required for the reaction [48,49]. There is debate as to
the importance or extent of binding-induced conforma-
tional changes to align active site residue side chains for
effective catalysis [50,51]. Regardless of the precise mal-
leability of the active site, in many cases amino acid
sidechains must form precise interactions with the sub-
strate to facilitate catalysis, and may involve acting as
donors or acceptors of protons, electrons or other groups
[52,53]; electrostatic interactions are important for transi-
tion state stabilisation [54]. There are forms of catalysis in
which the precise spatial arrangement of amino acid side
chains at the substrate binding site is not so important,
and the precise location of substrate binding is ill-defined
[55]. Where catalytic cofactors are utilised, their proper-
ties must be modulated, which is often achieved throughCurrent Opinion in Structural Biology 2018, 51:149–155
152 Engineering & designthe precise alignment and the effects of nearby amino
acids [56]. This has presented a challenge when it comes
to the design of de novo enzymes, although advances in
computing power for design and structure prediction are
facilitating this [4]. In the case of C45, despite the
dynamic nature of the protein, certain characteristics
imply that it is a stable, water impenetrable structure
[22]. Similar structural characteristics have been
observed in other de novo [36] and natural proteins
[57]. In many of these cases this may be due to the
substrate conferring structural homogeneity on the active
site, it remains to be experimentally determined whether
this is the case for C45.
It has been proposed that conformational flexibility may
have been an important mechanism in the evolution of
new reactivities in early enzymes [58]. It may therefore be
prudent to follow the example of nature by replicating the
characteristics of early enzymes in de novo designs before
iteration and directed evolution to refine and expand
function. Additionally, de novo proteins could serve as
models for early enzymes to gain insights into the evo-
lution of modern enzymes.
Some natural peroxidases, such as ascorbate peroxidase
[59], possess defined substrate-binding sites whereas
others, such as lignin peroxidase, have buried hemes
and do not have a well-defined cavity within the protein
but instead bind the substrate on the surface [55]. In the
case of surface-bound substrate, there is evidence to
suggest that long-range electron transfer pathways exist
to link the substrate to the buried heme via a catalytic
surface tryptophan residue [60–62], and C45 does have
surface Trp residues that could fulfil this role (Figure 2a),
as does lignin peroxidase [63,64] (Figure 2b). In the case
of C45, it performs efficient catalysis without a specificFigure 2
(a)
C45
(7.1 Å)
Trp43
Trp8
Trp80
(b)
(26.5 Å)
(25.2 Å)
Surface tryptophan residues in both C45 (a) and lignin peroxidase (PDB: 1B
from a surface-bound substrate to the protein-bound heme. Numbers in pa
tryptophan side chains and the conjugated porphyrin system of the bound h
Current Opinion in Structural Biology 2018, 51:149–155 binding site, and its substrate ABTS binds over the
protein surface (Figure 3b). By contrast, 2,4,6-trichloro-
phenol (TCP), to which C45 has a lower activity, may
bind in a specific place (Figure 3a). These findings
indicate that it may be that binding of the heme and
its immediate environment is more important for catalysis
than a snug binding pocket for the substrate.
While it has been suggested that the design of recessed
cavities in de novo enzymes is important [4], the success
of C45 shows that they are not always necessary for
efficient catalysis. Instead it may be profitable to focus
de novo design efforts on long-range efficient and rapid
electron transfer from surface-bound substrates. Further-
more, recent research by the DeGrado group has
highlighted the importance of designing the whole pro-
tein as a unit, with features far from the active site having
an impact on activity [65].
It is worth noting that defined structure may not be
essential for de novo protein functions other than catalysis.
The Hecht group have used a library approach of de novo
sequences to identify proteins that can rescue auxotroph
E. coli strains. Many of these proteins act on gene regula-
tion [66] and, there is evidence for some of these struc-
tures that, despite being highly stable, they do not form
well ordered structures in vitro [67].
The advantages of substrate promiscuity in de
novo protein design
The lack of highly specific substrate binding sites in many
natural peroxidases can lead to broad substrate promiscu-
ity, which we have observed in the case of C45, which can
catalyse a variety of peroxidase substrates including
guaiacol, reactive blue 4, and halogenated phenols
[22]. As theorised by Roy Jensen, primordial enzymesTrp171
Lignin peroxidase
(11.1 Å)
Current Opinion in Structural Biology
82) (b) which potentially participate in long-range electron transfer
rentheses represent the edge-to-edge distances between the
emes.
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Figure 3
(a)
TCP ABTS
ABTS
(b)
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Computational analysis of potential C45-substrate binding sites. While 2,4,6-trichlorophenol (TCP) (a) appears to preferentially bind in one position
on C45, the larger ABTS (2,20-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) molecule (b) appears to bind indiscriminately across the surface.
The data presented is derived from docking analysis performed by the Bristol University Docking Engine (BUDE) [22] in conjunction with
molecular dynamics simulations. Overlays are shown here for representative low energy binding poses for TCP and ABTS.were catalytically promiscuous, then evolved to perform
more specific and/or active function [68]. Thus, we may
take inspiration from nature and design de novo enzymes
without specificity, then evolve to improve or narrow
selectivity. This theory of the evolution of proteins from
generalists to specialists [69] has been tested using de novo
protein design by the Hecht group [18,70]. This was done
through the use of combinatorial libraries of protein
sequences designed with binary patterning principles,
in which the polar and non polar nature of residues is
selected and patterned to build a particular secondary
structure — in this case 4-helix bundles. The majority of
the proteins that were expressed could bind b-type heme,
and most of those exhibited peroxidase activity and
exhibited catalytic promiscuity. A small amount of the
de novo proteins were hydrolases with lipase and esterase
activity (activities that do not depend on bound heme).
These results demonstrate that achieving catalytic ability
and/or substrate binding is not difficult in unevolved
protein sequences [18].
In many natural enzymes specificity is often vitally impor-
tant to stringently distinguish between substrates, such is
the case with restriction endonucleases [71,72]. But for
the purposes of de novo enzymes, this fidelity may not be
strictly necessary. For example, in an industrial reaction
in which only one substrate is fed into the reaction, tight
control over promiscuity is not necessary as long as the
desired product is produced effectively and efficiently. In
fact promiscuity may be an advantage as one enzyme may
be able to perform various different reactions as desired,
providing the reaction energetically favours the creation
of the product over the back reaction. Many natural
proteins exhibit substrate promiscuity, including HRP,
making it useful for many biotechnological applications
[73].www.sciencedirect.com While the substrate promiscuity of C45 may be advanta-
geous, it also lends the opportunity to employ both
rational protein design and directed evolution methodol-
ogies to optimize the catalytic chassis towards a selected
substrate or chemical mechanism. This will be facilitated
by the fact that C45 is fully assembled (and functional) in
vivo.
Conclusions and future directions for de novo
enzyme design
C45 is an example of how a catalytically productive de
novo enzyme was achieved with relative ease, without a
defined substrate binding site or strict specificity. The
simplicity of the C45 design provides a basic and flexible
scaffold which lends itself to further modifications to
achieve new functions. For an example, we anticipate
that C45 may perform other natural and artificial reac-
tions, such as carbene and nitrene transfer, and may
provide a platform for accessing powerful hydroxylase
chemistries.
Based on the success of the C45 design we propose that
future catalytic protein design will be aided by taking a
bottom-up approach, using simple scaffolds as a starting
point. Rather than focussing on highly specific and effi-
cient catalysis, we should take inspiration from the evo-
lution of natural proteins, in which promiscuity provides
the starting point for refined reactivities. While the design
of active sites is a worthwhile goal, in certain cases they
may not be necessary and instead treating the protein as a
reactive surface with networks of interactions across the
structure may be beneficial.
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